154 related articles for article (PubMed ID: 10713012)
1. Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS.
van Heerden PV; Barden A; Michalopoulos N; Bulsara MK; Roberts BL
Chest; 2000 Mar; 117(3):819-27. PubMed ID: 10713012
[TBL] [Abstract][Full Text] [Related]
2. Systemic levels of 6-keto-prostaglandin F1 alpha following administration of inhaled aerosolized prostacyclin.
van Heerden PV
Anaesth Intensive Care; 1997 Dec; 25(6):701-3. PubMed ID: 9452859
[TBL] [Abstract][Full Text] [Related]
3. Description and evaluation of a delivery system for aerosolized prostacyclin.
Siobal MS; Kallet RH; Pittet JF; Warnecke EL; Kraemer RW; Venkayya RV; Tang JF
Respir Care; 2003 Aug; 48(8):742-53. PubMed ID: 12890294
[TBL] [Abstract][Full Text] [Related]
4. Inhaled aerosolized prostacyclin as a selective pulmonary vasodilator for the treatment of severe hypoxaemia.
Van Heerden PV; Webb SA; Hee G; Corkeron M; Thompson WR
Anaesth Intensive Care; 1996 Feb; 24(1):87-90. PubMed ID: 8669661
[TBL] [Abstract][Full Text] [Related]
5. The role of inhaled prostacyclin in treating acute respiratory distress syndrome.
Searcy RJ; Morales JR; Ferreira JA; Johnson DW
Ther Adv Respir Dis; 2015 Dec; 9(6):302-12. PubMed ID: 26294418
[TBL] [Abstract][Full Text] [Related]
6. Inhaled aerosolized prostacyclin and nitric oxide as selective pulmonary vasodilators in ARDS--a pilot study.
Van Heerden PV; Blythe D; Webb SA
Anaesth Intensive Care; 1996 Oct; 24(5):564-8. PubMed ID: 8909667
[TBL] [Abstract][Full Text] [Related]
7. Severity of Hypoxemia and Other Factors That Influence the Response to Aerosolized Prostacyclin in ARDS.
Kallet RH; Burns G; Zhuo H; Ho K; Phillips JS; Pangilinan LP; Yip V; Gomez A; Lipnick MS
Respir Care; 2017 Aug; 62(8):1014-1022. PubMed ID: 28559468
[TBL] [Abstract][Full Text] [Related]
8. Inhaled prostaglandin E1 for treatment of acute lung injury in severe multiple organ failure.
Meyer J; Theilmeier G; Van Aken H; Bone HG; Busse H; Waurick R; Hinder F; Booke M
Anesth Analg; 1998 Apr; 86(4):753-8. PubMed ID: 9539597
[TBL] [Abstract][Full Text] [Related]
9. Effect of aerosolized prostacyclin and inhaled nitric oxide on experimental hypoxic pulmonary hypertension.
Max M; Kuhlen R; Dembinski R; Rossaint R
Intensive Care Med; 1999 Oct; 25(10):1147-54. PubMed ID: 10551974
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic and oxygenation changes of combined therapy with inhaled nitric oxide and inhaled aerosolized prostacyclin.
Rocca GD; Coccia C; Pompei L; Ruberto F; Venuta F; De Giacomo T; Pietropaoli P
J Cardiothorac Vasc Anesth; 2001 Apr; 15(2):224-7. PubMed ID: 11312484
[TBL] [Abstract][Full Text] [Related]
11. Randomized controlled trial of aerosolized prostacyclin therapy in children with acute lung injury.
Dahlem P; van Aalderen WM; de Neef M; Dijkgraaf MG; Bos AP
Crit Care Med; 2004 Apr; 32(4):1055-60. PubMed ID: 15071401
[TBL] [Abstract][Full Text] [Related]
12. Nebulized prostacyclin (PGI2) in acute respiratory distress syndrome: impact of primary (pulmonary injury) and secondary (extrapulmonary injury) disease on gas exchange response.
Domenighetti G; Stricker H; Waldispuehl B
Crit Care Med; 2001 Jan; 29(1):57-62. PubMed ID: 11176161
[TBL] [Abstract][Full Text] [Related]
13. Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome.
Zwissler B; Kemming G; Habler O; Kleen M; Merkel M; Haller M; Briegel J; Welte M; Peter K
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1671-7. PubMed ID: 8970353
[TBL] [Abstract][Full Text] [Related]
14. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome.
Walmrath D; Schneider T; Schermuly R; Olschewski H; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1996 Mar; 153(3):991-6. PubMed ID: 8630585
[TBL] [Abstract][Full Text] [Related]
15. Inhaled aerosolized prostaglandin E1, pulmonary hemodynamics, and oxygenation during lung transplantation.
Della Rocca G; Coccia C; Pompei L; Costa MG; Di Marco P; Pietropaoli P
Minerva Anestesiol; 2008 Nov; 74(11):627-33. PubMed ID: 18971891
[TBL] [Abstract][Full Text] [Related]
16. Re: Delivery of inhaled aerosolized prostacyclin (IAP).
van Heerden PV; Power BM; Leonard RC
Anaesth Intensive Care; 1996 Oct; 24(5):624-5. PubMed ID: 8909691
[No Abstract] [Full Text] [Related]
17. Inhaled epoprostenol improves oxygenation in severe hypoxemia.
Tabrizi MB; Schinco MA; Tepas JJ; Hwang J; Spiwak E; Kerwin AJ
J Trauma Acute Care Surg; 2012 Aug; 73(2):503-6. PubMed ID: 23019678
[TBL] [Abstract][Full Text] [Related]
18. Aerosolized prostacyclin and inhaled nitric oxide in septic shock--different effects on splanchnic oxygenation?
Eichelbrönner O; Reinelt H; Wiedeck H; Mezödy M; Rossaint R; Georgieff M; Radermacher P
Intensive Care Med; 1996 Sep; 22(9):880-7. PubMed ID: 8905421
[TBL] [Abstract][Full Text] [Related]
19. Noninferiority of Inhaled Epoprostenol to Inhaled Nitric Oxide for the Treatment of ARDS.
Ammar MA; Bauer SR; Bass SN; Sasidhar M; Mullin R; Lam SW
Ann Pharmacother; 2015 Oct; 49(10):1105-12. PubMed ID: 26187741
[TBL] [Abstract][Full Text] [Related]
20. Retrospective evaluation of inhaled prostaglandins in patients with acute respiratory distress syndrome.
Camamo JM; McCoy RH; Erstad BL
Pharmacotherapy; 2005 Feb; 25(2):184-90. PubMed ID: 15767234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
